Skip to main content
Ipsen Home Page
Press shift tab to select search category

Loading...
  • Media arrow down
      < Back
    • Media
    • Press Releases
  • Investors
  • Partnering
  • Careers arrow down
      < Back
    • Careers
    • Careers
    • Working at Ipsen
    • Culture
  • Press shift tab to select search category

    Loading...
  • Global United States
    < Back
    • Global
    • Annual Report
    • Americas
    • Asia Pacific
    • Europe
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Czech Republic
    • Switzerland
    • Austria
  • Home
  • Companyarrow down
      < Back
    • Company
    • Who We Are
    • Leadership
    • Our History
  • Sciencearrow down
      < Back
    • Science
    • Areas of focus
    • Products
    • Clinical Trials
    • R&D
    • Grant Requests
    • Investigator Sponsored Studies
  • Responsibilityarrow down
      < Back
    • Responsibility
    • Responsibility
    • Environment
    • People
    • Governance
    • Charitable Donations 
  • Patientsarrow down
      < Back
    • Patients
    • Patients
    • Early Access Public Policy
  • Stories
  1. Home
  2. Who We Are
  3. Leadership
  4. Eduardo Molina

Eduardo Molina

Back
Eduardo Molina

Eduardo Molina

  • Vice President,
  • Business Operations & Strategy and Chief of Staff
  • Follow in LinkedIn

Eduardo joined Ipsen in September 2024, bringing both U.S. and global experience with deep strategic and operational understanding in hematology/oncology and rare disease launches.

In Eduardo’s role, he will be responsible for leading our Business Operations team to support our growing and evolving U.S. business. In addition, he will serve as Chief of Staff to the President of North America.

Eduardo joined Ipsen from bluebird bio where he served as VP, Marketing, Strategy and Analytics, leading the marketing strategy and execution for gene therapy launches in hematology/rare diseases. Prior to that, he served as Head of U.S. Marketing for Reblozyl for Merck/Acceleron and as the global commercial team leader for Venclexta at Abbvie, both during their critical U.S. launch period. Eduardo also spent a number of years during his career at Novartis Oncology, working in a variety of U.S., Global and Regional roles of increasing responsibility across sales, marketing and strategy.

Eduardo received his MBA from The Wharton School and Masters of International Studies from the Lauder Institute at the University of Pennsylvania.

IPN price

€103.70

 €1.40 (1.37%)

  • Media
  • Investors
  • Partnering
  • Contact us
  • Leadership
  • Responsibility
  • Patients
  • Stories
  • Compliance
  • U.S. State Pricing Disclosures
  • Vigilance Alert: Identity Theft

Latest_Ipsen logo
LinkedIn Facebook Instagram Youtube
  • Terms of Use
  • Privacy
  • Consumer Health Data Privacy
  • Cookies
  • Your Privacy Choices

© Ipsen Biopharmaceuticals, Inc. All rights reserved - 2025

You are now leaving the Ipsen US website. To continue, please click on continue.

Continue